Comparative study of specific activity of the piroctone olamine semisolid dosage form for external use

V. V. Hladyshev, D. Romanina, O. B. Kharaponova, N. L. Kolycheva, I. V. Hnitko, I. O. Pukhalska, H. P. Lysianska
{"title":"Comparative study of specific activity of the piroctone olamine semisolid dosage form for external use","authors":"V. V. Hladyshev, D. Romanina, O. B. Kharaponova, N. L. Kolycheva, I. V. Hnitko, I. O. Pukhalska, H. P. Lysianska","doi":"10.14739/2409-2932.2022.2.258934","DOIUrl":null,"url":null,"abstract":"The external treatment of seborrheic dermatitis of the scalp depends on the withdrawal of clinical symptoms and the complaints the patient made to the doctor. At present Ukrainian dermatology has several dozen pharmacotherapeutic products in this direction, with dominating medicines of ketoconazole, zinc pyrition, and their combinations.\nThey are characterized by the short-term or weak effect, associated with the pathogenic microorganisms’ resistance against the background of long-term use of biologically active substances which are their active parts. One way to solve the problem is using the drugs with new highly active pharmaceutical ingredients.\nEmployees of the Department of Technology of Medications of the Zaporizhzhia State Medical University proposed the composition of a new applicate semisolid dosage form of pirocton olamine based on complex physical-chemical, pharmacotechnological, biopharmaceutical, and rheological investigations – topical ointment on the hydrophilic base in combination with resin-free naphthalene for external use in the complex etiotropic treatment of seborrheic dermatitis of the scalp.\nThe aim of this work is to study the specific activity of the combined ointment with pirocton olamine and resin-free naphthalene on a hydrophilic vehicle.\nMaterials and methods. As the object of preclinical studies used experimental ointment containing 1 % piroctone olamine and 5 % resin-free naphthalene on the base of sodium carboxymethylcellulose glycerogel, providing optimum release of active pharmaceutical ingredients from the vehicle, and appropriate placebo semisolid dosage form. The study of the specific activity of the developed ointment under the conditional name “Oktonaf” was carried out by evaluating its antimicrobial, anti-inflammatory, and antioxidant effects given the foreseeable therapeutic focus and the literature on the spectrum of biological activity of active substances.\nThe anti-inflammatory and antioxidant action of the proposed composition was evaluated by the allergic contact dermatitis model. As a reference drug cream “Psoricap” (KMP, Ukraine), which has long been applied in dermatological practice was used.\nResults of comparative microbiological studies proved that composite anti-seborrheic ointment with piroctone olamine and resin-free naphthalene by the antibacterial effect in relation to the size of the growth delay zones for Staphylococcus aureus and Escherichia coli (gram-positive and gram-negative microorganisms) slightly exceeds the effective dermatological medication reference cream “Psoricap”. At the same time, the antimycotic activity of experimental ointment in relation to Candida albicans practically does not differ from the same reference drug.\nA study of antioxidant and anti-inflammatory activity of the developed piroctone olamine ointment on a hydrophilic basis using the model of allergic contact dermatitis revealed that its level reliably was exceed the efficacy of topical reference medication “Psoricap”.\nConclusions. Obtained data of a spectrum of specific activity of a combined ointment with piroctone olamine and resin-free naphthalene can predict the high clinical value of the proposed drug for practical domestic dermatology.\n ","PeriodicalId":10800,"journal":{"name":"Current issues in pharmacy and medicine: science and practice","volume":"82 2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current issues in pharmacy and medicine: science and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14739/2409-2932.2022.2.258934","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The external treatment of seborrheic dermatitis of the scalp depends on the withdrawal of clinical symptoms and the complaints the patient made to the doctor. At present Ukrainian dermatology has several dozen pharmacotherapeutic products in this direction, with dominating medicines of ketoconazole, zinc pyrition, and their combinations. They are characterized by the short-term or weak effect, associated with the pathogenic microorganisms’ resistance against the background of long-term use of biologically active substances which are their active parts. One way to solve the problem is using the drugs with new highly active pharmaceutical ingredients. Employees of the Department of Technology of Medications of the Zaporizhzhia State Medical University proposed the composition of a new applicate semisolid dosage form of pirocton olamine based on complex physical-chemical, pharmacotechnological, biopharmaceutical, and rheological investigations – topical ointment on the hydrophilic base in combination with resin-free naphthalene for external use in the complex etiotropic treatment of seborrheic dermatitis of the scalp. The aim of this work is to study the specific activity of the combined ointment with pirocton olamine and resin-free naphthalene on a hydrophilic vehicle. Materials and methods. As the object of preclinical studies used experimental ointment containing 1 % piroctone olamine and 5 % resin-free naphthalene on the base of sodium carboxymethylcellulose glycerogel, providing optimum release of active pharmaceutical ingredients from the vehicle, and appropriate placebo semisolid dosage form. The study of the specific activity of the developed ointment under the conditional name “Oktonaf” was carried out by evaluating its antimicrobial, anti-inflammatory, and antioxidant effects given the foreseeable therapeutic focus and the literature on the spectrum of biological activity of active substances. The anti-inflammatory and antioxidant action of the proposed composition was evaluated by the allergic contact dermatitis model. As a reference drug cream “Psoricap” (KMP, Ukraine), which has long been applied in dermatological practice was used. Results of comparative microbiological studies proved that composite anti-seborrheic ointment with piroctone olamine and resin-free naphthalene by the antibacterial effect in relation to the size of the growth delay zones for Staphylococcus aureus and Escherichia coli (gram-positive and gram-negative microorganisms) slightly exceeds the effective dermatological medication reference cream “Psoricap”. At the same time, the antimycotic activity of experimental ointment in relation to Candida albicans practically does not differ from the same reference drug. A study of antioxidant and anti-inflammatory activity of the developed piroctone olamine ointment on a hydrophilic basis using the model of allergic contact dermatitis revealed that its level reliably was exceed the efficacy of topical reference medication “Psoricap”. Conclusions. Obtained data of a spectrum of specific activity of a combined ointment with piroctone olamine and resin-free naphthalene can predict the high clinical value of the proposed drug for practical domestic dermatology.  
吡洛酮胺外用半固体剂型比活性的比较研究
头皮脂溢性皮炎的外部治疗取决于临床症状的消退和患者向医生提出的投诉。目前,乌克兰皮肤科在这方面有几十种药物治疗产品,主要药物是酮康唑、吡啶锌及其组合。它们的特点是短期或弱作用,与长期使用作为其活性部分的生物活性物质的背景下病原微生物的耐药性有关。解决这一问题的方法之一是使用含有新型高活性药物成分的药物。中国国立医科大学药物技术系的工作人员在复杂的理化、药物工艺、生物制药和流变学研究的基础上,提出了一种新的应用半固体剂型吡罗通胺的组合——在亲水性基础上与无树脂萘联合外用外用外用外用软膏,用于头皮脂溢性皮炎的复杂致病因治疗。本研究的目的是研究吡唑酮胺和无树脂萘复合软膏在亲水性载体上的比活性。材料和方法。作为临床前研究的对象,在羧甲基纤维素甘油凝胶钠的基础上,采用含有1%吡洛酮胺和5%无树脂萘的实验软膏,提供了最佳的药物活性成分从载体中释放,以及合适的安慰剂半固体剂型。考虑到可预见的治疗重点和有关活性物质生物活性谱的文献,通过评价其抗菌、抗炎和抗氧化作用,对所开发的软膏进行了比活性研究,条件名称为“Oktonaf”。该组合物的抗炎和抗氧化作用通过过敏性接触性皮炎模型进行评价。参考药膏“Psoricap”(KMP,乌克兰),在皮肤科实践中应用已久。对比微生物学研究结果证明,复合抗脂流软膏中含有吡洛酮olamine和无树脂萘,其抑菌效果与对金黄色葡萄球菌和大肠杆菌(革兰氏阳性和革兰氏阴性微生物)生长延迟区大小的关系略高于有效的皮肤科用药参考霜“Psoricap”。同时,实验软膏对白色念珠菌的抗真菌活性实际上与相同的参比药物没有区别。利用变态反应性接触性皮炎模型对所研制的吡洛酮胺软膏的抗氧化和抗炎活性进行了亲水性研究,结果表明其抗氧化和抗炎活性可靠地超过了外用参考药物“Psoricap”的疗效。获得的吡洛通胺和无树脂萘联合软膏的比活性谱数据可以预测该药物在实际的国内皮肤病学中具有很高的临床价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信